Chest Pain Evidence-Based Diagnosis
Severe, Crushing Chest Pain suggesting Myocardial Infarction
- Severe, crushing, central chest pain, often radiating to the left arm, jaw or neck, potentially accompanied by sweating (diaphoresis), nausea, or shortness of breath.
- Evidence: Classic cardiac pain features increase likelihood of ACS; studies report Positive Likelihood Ratios (LR+) generally ranging from ~2 to 7 for features like radiation to arms/shoulders. Positive Predictive Value (PPV) varies widely by clinical setting (estimated ~5-15% in primary care, higher in ED).
- Reference: Body R et al. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation. 2010;81(3):281-6. and NICE Guideline NG185: Acute coronary syndromes (2020).
- Significance: History suggestive of cardiac pain significantly increases the probability of Myocardial Infarction (MI) or unstable Angina (collectively Acute Coronary Syndrome - ACS). Requires immediate cardiac workup (ECG, Troponin), especially in patients with risk factors. However, sensitivity is limited; atypical presentations (e.g., epigastric pain, isolated dyspnoea) are common, particularly in women, elderly individuals, and those with diabetes.
- Clinical Reasoning Tip: Prioritise ruling out ACS in patients describing typical cardiac pain features. Use these features to raise suspicion but do not rely on them to rule out ACS, especially in high-risk or atypical groups. Combine history with ECG, troponin, and risk stratification scores (e.g., HEART).
Pleuritic Chest Pain suggesting Pulmonary Embolism or Pneumonia
- Sharp, stabbing chest pain, worsened by inspiration or coughing.
- Evidence: While included in clinical prediction rules (e.g., Wells'), evidence indicates pleuritic pain has modest diagnostic value in isolation for PE (Positive Likelihood Ratio often < 2). Guidelines note its frequent association with pulmonary/pleural conditions like Pneumonia.
- Reference: NICE Guideline NG158: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2020). and NICE Clinical Guideline CG191: Pneumonia in adults: diagnosis and management (2014).
- Significance: Pleuritic chest pain increases the probability of pulmonary or pleural causes like Pulmonary Embolism (PE), Pneumonia, Pleurisy, Pericarditis, Pneumothorax, and can occur with Costochondritis. It makes typical cardiac ischaemia less likely but doesn't exclude it. Not sensitive or specific enough for diagnosis alone.
- Clinical Reasoning Tip: Pleuritic chest pain prompts consideration of pulmonary/pleural causes. Combine this feature with risk factors (for PE), associated symptoms (fever/cough for Pneumonia), and relevant investigations (D-dimer, CXR, CTPA) to guide diagnosis.
Chest Wall Tenderness suggesting Musculoskeletal Chest Pain
- Chest pain reproducible by palpation of the chest wall muscles, ribs, or costochondral junctions.
- Evidence: Studies consistently show reproducible chest wall tenderness has high specificity (often reported as >85%) for supporting a musculoskeletal diagnosis, though sensitivity is lower and more variable (reported range ~20% to 75%).
- Reference: Verdon F et al. Chest wall syndrome: a common cause of chest pain. Prim Care Companion J Clin Psychiatry. 2007;9(5):391-3. and Ayloo A et al. Diagnosis and management of musculoskeletal chest pain. Am Fam Physician. 2013;88(11):757-62.
- Significance: High specificity means its presence strongly supports a musculoskeletal diagnosis. However, low sensitivity means its absence does not rule it out. Importantly, musculoskeletal tenderness can occasionally co-exist with serious pathology (e.g., ACS).
- Clinical Reasoning Tip: Routinely palpate the chest wall. Reproducible tenderness strongly suggests a musculoskeletal cause, but *always* consider and exclude serious underlying conditions (like ACS) based on the overall clinical picture before attributing pain solely to this finding.
Heartburn and Acid Regurgitation suggesting GORD
- Retrosternal burning pain ('heartburn'), often worse after meals, spicy food, alcohol, or lying flat, possibly relieved by antacids, and often associated with acid regurgitation into the mouth.
- Evidence: Symptom-based diagnosis using typical features has moderate accuracy for GORD (Sensitivity often ~60-70%, Specificity ~70-80%), according to consensus definitions. Diagnostic confidence increases significantly with a positive response to a PPI trial, as recommended by NICE guidance.
- Reference: Vakil N et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900-20. and NICE Clinical Knowledge Summary (CKS): Dyspepsia - proven GORD (Updated Jan 2023).
- Significance: Typical symptoms significantly increase the probability of Gastro-oesophageal Reflux Disease (GORD). Atypical chest pain presentations of GORD are common and harder to distinguish from cardiac pain. Consider GORD especially if symptoms are chronic, meal-related, postural, or respond to antacids/PPIs.
- Clinical Reasoning Tip: Thoroughly explore symptoms for typical GORD features. An empirical trial of PPI therapy can be both diagnostic and therapeutic in suspected cases *after* serious cardiac causes have been reasonably excluded based on risk assessment, ECG, and potentially troponins. Beware the 'cardiac masquerade'.
Anxiety Symptoms suggesting Panic Disorder as cause of Chest Pain
- Episodic chest pain occurring during a discrete period of intense fear or discomfort, accompanied by characteristic panic symptoms (e.g., palpitations, sweating, trembling, shortness of breath, choking feeling, dizziness, derealisation, fear of dying/losing control).
- Evidence: While criteria (e.g., DSM-5) accurately diagnose Panic Disorder itself, attributing chest pain solely to panic requires excluding organic causes. Studies indicate Panic Disorder is present in a significant proportion (estimated ~20-40%) of patients presenting with non-cardiac chest pain.
- Reference: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision (DSM-5-TR). 2022. and NICE Clinical Guideline CG113: Generalised anxiety disorder and panic disorder in adults: management (2011, updated 2019).
- Significance: Co-existing panic attack symptoms increase the likelihood that Anxiety/Panic Disorder is contributing to or is the primary cause of the chest pain episode, *once life-threatening organic causes have been excluded*.
- Clinical Reasoning Tip: Consider anxiety/panic in the differential, especially with typical panic features during episodes and known history. However, it remains a diagnosis of exclusion for the chest pain itself. Use validated screening tools (e.g., GAD-7, PHQ-9 for co-morbidity) and address anxiety, but ensure cardiac/pulmonary causes are ruled out first according to risk stratification.
Reduced Oxygen Saturation (SpO2 <95% on room air) suggesting Pulmonary Pathology
- Oxygen saturation measured by pulse oximetry persistently below 95% (or below patient's baseline if known chronic lung disease) breathing room air.
- Evidence: Guidelines (e.g., BTS) define hypoxaemia thresholds (typically <94-95%) as indicating significant cardiorespiratory compromise and illness severity. While sensitivity for severe conditions like major PE or pneumonia can be moderate (~50-80%), specificity is low as it reflects physiological state, not a specific diagnosis.
- Reference: British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings (2017). and Freund Y et al. Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial. JAMA. 2018;319(6):559-566. (Notes SpO2 threshold in PERC rule).
- Significance: Hypoxaemia strongly suggests significant underlying pathology affecting gas exchange, increasing the probability of Pulmonary Embolism, Pneumonia, Pneumothorax, COVID-19, or severe Acute Heart Failure (e.g., post-MI pulmonary oedema). It's a marker of severity requiring urgent investigation and potential oxygen therapy. Normal SpO2 *does not* exclude these conditions, particularly smaller PEs or early pneumonia.
- Clinical Reasoning Tip: Measure SpO2 routinely. Hypoxaemia (<95% or drop from baseline) is a crucial red flag indicating significant illness. Prioritise investigations for pulmonary and severe cardiac causes. Remember normal SpO2 doesn't rule out serious pathology.
Elevated Troponin Levels confirming Myocardial Infarction
- Elevated cardiac troponin level (high-sensitivity assay preferred) above the 99th percentile upper reference limit, ideally with a significant rise and/or fall pattern on serial testing, consistent with the clinical picture.
- Evidence: Guidelines (e.g., NICE, ESC) state high-sensitivity troponin assays, used with validated serial testing algorithms (e.g., 0/1h or 0/3h), achieve very high sensitivity (often >95%) and Negative Predictive Value (>99%) for ruling out MI. Specificity is lower (~80-90%) due to other causes of myocardial injury.
- Reference: NICE Guideline NG185: Acute coronary syndromes (2020). and Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264.
- Significance: A dynamic change (rise/fall) in hs-cTn above the 99th percentile confirms acute myocardial injury and, in the context of ischaemic symptoms/signs, defines Myocardial Infarction (MI). Guides urgent ACS management pathway. Persistently elevated levels without dynamic change suggest chronic injury or non-ACS causes (e.g., heart failure, PE, sepsis, renal failure, myocarditis).
- Clinical Reasoning Tip: Use hs-cTn assays and guideline-recommended serial testing algorithms (e.g., NICE 0/1h or 0/3h pathways) for rapid rule-in/rule-out of MI. Very high NPV allows safe discharge for low-risk patients with negative serial results. Always interpret troponin levels in the clinical context (history, ECG, risk factors) and consider non-ACS causes for elevations without a clear dynamic change or ischaemic picture.
ST-Segment Elevation on ECG confirming STEMI
- New ST-segment elevation at the J-point in ≥2 contiguous leads meeting voltage criteria (e.g., ≥1mm in limb leads, ≥2mm in V2-V3 [adjusted for age/sex], ≥1.5mm in women in V2-V3), or new LBBB assumed to be ischaemic.
- Evidence: Guidelines confirm ST-segment elevation meeting criteria has high specificity (>90%) but moderate sensitivity (~45-55%) for identifying acute coronary occlusion causing STEMI, as many MIs are NSTEMI.
- Reference: Collet JP et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. (Defines STEMI criteria) and NICE Guideline NG185: Acute coronary syndromes (2020).
- Significance: ST-elevation fulfilling criteria is diagnostic of STEMI, indicating acute, ongoing transmural myocardial injury typically due to complete coronary artery occlusion. Requires immediate reperfusion therapy (Primary PCI preferred in UK, or thrombolysis if unavailable promptly).
- Clinical Reasoning Tip: Recognise STEMI criteria instantly. This is a time-critical emergency requiring immediate activation of the local reperfusion pathway (e.g., direct call to cath lab). Be aware of STEMI equivalents (new LBBB, posterior MI signs) and evolving changes (hyperacute T waves).
Elevated D-dimer with appropriate Clinical Probability for Pulmonary Embolism
- Elevated D-dimer level (using an age-adjusted threshold where appropriate) in a patient assessed to have a low or moderate pre-test probability of Pulmonary Embolism (PE) using a validated score (e.g., Wells', revised Geneva). Not typically used if pre-test probability is high.
- Evidence: Guidelines confirm D-dimer testing has high sensitivity (often >95%) but low specificity (highly variable, ~40-60%) for PE. Its key value lies in the very high Negative Predictive Value (>99%) when combined with a low clinical pre-test probability, allowing safe rule-out.
- Reference: NICE Guideline NG158: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2020). and Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.
- Significance: A *negative* D-dimer in a patient deemed low clinical risk effectively excludes Pulmonary Embolism (PE). An *elevated* D-dimer does *not* confirm PE due to low specificity (many other causes) but mandates further investigation (usually CTPA) if clinical suspicion persists (i.e., in moderate/high risk groups or if low risk assessment was borderline).
- Clinical Reasoning Tip: Use D-dimer testing *selectively* as part of a PE diagnostic algorithm, incorporating pre-test probability assessment (e.g., Wells' score or clinician gestalt guided by PERC rule criteria if applicable). Primarily used to *rule out* PE in low-risk patients to avoid unnecessary imaging. Do not use D-dimer if clinical probability is high (proceed direct to imaging). Remember age-adjustment improves specificity in older adults.
Consolidation on Chest X-ray confirming Pneumonia
- Opacification (consolidation) on chest radiograph consistent with alveolar filling, often lobar or segmental, in a patient with clinical features of lower respiratory tract infection (e.g., cough, fever, purulent sputum, pleuritic pain, focal chest signs).
- Evidence: Evidence synthesis suggests Chest X-ray has moderate sensitivity (estimated range ~70-80%) and higher specificity (range ~85-95%) for diagnosing typical bacterial Pneumonia presenting as consolidation, compared to clinical assessment alone.
- Reference: NICE Clinical Guideline CG191: Pneumonia in adults: diagnosis and management (2014). and Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67.
- Significance: The presence of new consolidation on CXR strongly supports the diagnosis of Pneumonia in the right clinical context, guiding antibiotic choice and severity assessment (e.g., using CURB-65 score). A normal CXR makes typical bacterial pneumonia less likely but doesn't exclude it entirely, nor does it exclude other causes of the patient's symptoms.
- Clinical Reasoning Tip: Obtain a CXR in patients with suspected pneumonia (clinical signs + systemic features). Consolidation confirms the diagnosis. Interpret CXR findings alongside clinical features and inflammatory markers (CRP). Consider alternative diagnoses or further imaging (CT) if CXR is negative but clinical suspicion remains high, or if complications are suspected.